Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for exercise capacity in COPD and pulmonary hypertension
NCT01197469Phase 2Completed
- Sponsor
- University of Dundee
- Start
- Sep 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary hypertension (PH) comparing Tadalafil with Placebo (2 arms). Primary endpoint: 6 minute walking distance at 3 months. Started Sep 2010; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01197469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197469.